Ratios
10-year key figure history for AcuCort turnover, profit, dividend, equity, PE and PB.
Stockprice
Price movement for AcuCort with index and moving average MA50 and MA200.
Description
AcuCort develops and commercializes Dexa ODF - a drug in the form of a fast-dissolving film to apply to the tongue, based on a well-known glucocorticoid - dexamethasone. In the development of Dexa ODF, the benefits of the well-used and documented substance dexamethasone and the fast-dissolving film have been combined in a product that is tailored for quick availability and relief in emergency situations. AcuCort will develop and commercialize Dexa ODF using a global network of licensees and / or distributors. AcuCort will identify, develop and commercialize complementary smart drugs that have a relatively short time to launch and are based on existing substances.